Clinical Trials › NCT04075266
Active, Not RecruitingPhase 2
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
Sponsored by Hoffmann-La Roche
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 23
Target enrollment
5
U.S. states
Jan 2020
Start date
Dec 2029
Expected completion
Interventions / Treatments
Ocrelizumab
Conditions studied
Multiple Sclerosis
Where this trial is running (5 sites)
Colorado1 site
Aurora
District of Columbia1 site
Washington D.C.
Massachusetts1 site
Boston
Missouri1 site
St Louis
Ohio1 site
Cleveland
Participating MS centers on MS Buddy (4)
John L. Trotter Multiple Sclerosis Center
Saint Louis, MO
Saint Louis, MO
Mellen Center for MS Treatment & Research
Cleveland, OH
Cleveland, OH
MS centers in Colorado
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Colorado centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
